While semaglutide is already approved for Type 2 diabetes and obesity, its use in Type 1 diabetes remains investigational
Phentermine was half of the infamous fen-phen combination (fenfluramine-phentermine) that was pulled from the market in the 1990s after causing heart valve damage and pulmonary hypertension
Commercial insurance only covers the drug approximately 30% of the time when prescribed for weight loss
H2H = Head-to-Head comparison.) Potential for Breaking Plateaus/Additional Loss: Based on its demonstrated higher efficacy, switching from semaglutide to tirzepatide might help some individuals break through a weight loss plateau or achieve additional weight loss
Many healthcare systems offer injection training with diabetes educators or nurses, which can be invaluable for patients new to self-injection or those experiencing persistent injection site issues
Even after reaching a target weight, many patients continue semaglutide often at a smaller dose to support chronic weight management and keep the weight off